載入...
ErbB-2 Signaling in Advanced Prostate Cancer Progression and Potential Therapy
Currently, prostate cancer (PCa) remains the most commonly diagnosed solid tumor and the second leading cause of cancer-related deaths in U.S. men. Most of these deaths are attributed to the development of castration-resistant (CR) PCa. ErbB-2 and ErbB family members have been demonstrated to contri...
Na minha lista:
| 發表在: | Endocr Relat Cancer |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6628717/ https://ncbi.nlm.nih.gov/pubmed/31294537 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-19-0009 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|